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Resumen: Actualmente, en E.E.U.U los esfuerzos a favor de los programas de reducción de daños en materia de
drogas son mínimos, a pesar de que estos programas aparecieran en los años 70. El sistema de justicia penal se ha
convertido, desde los años 80, en el elemento predominante para controlar a los usuarios de drogas ilegales. Esto
se refleja en el aumento del número de detenciones relacionadas con las drogas, así como en un mayor número de
personas en prisión condenadas por este tipo de delitos. A pesar de, y en algunos casos como reacción a la
considerable generalización del uso del derecho penal y el encarcelamiento para hacer frente a la delincuencia
relacionada con la droga, las políticas de reducción de daños están apareciendo en varios estados, particularmente
en el oeste.
Laburpena: Nahiz eta 70. hamarkadan jaio ziren min murrizketa programak, gaur egun Estatu Batuetan ez da
beraien alde gauza gehiegirik egiten Justizi penalaren sistema 80. hamarkadatik bihurtu da kontrol sistemarik
garrantzitsuena drogen arloan. Honek bere islada hainbat eta hainbat atxiloketetan du, baita kartzelan arazo
honengatik dagoen jende kopuruan. Hala ere esan daiteke, nahiz eta gero eta era orokorragoz kartzela zigorren
bidez egiten zaion aurre drogen arazoei, esan beharra dago, gero eta erreztasun handiagoz erabiltzen hasten direla
mina murrizten duten politika programak.
Résumé: Actuellement, en E.E.U.U les efforts en faveur des programmes de réduction de dommages en matière
de drogues sont minimaux, bien que ces programmes apparaissent dans les années 70. Le système de justice
pénale est devenu, depuis les années 80, l’élément prédominant pour contrôler aux consommateurs des drogues
illégales. Ceci se reflète dans l’augmentation du nombre de détentions en rapport avec les drogues, ainsi que dans
un plus grand nombre de personnes en prison condamnées par ce type d’infractions. Malgré, et dans quelques cas
comme réaction, la généralisation de l’utilisation du droit pénal et l’emprisonnement pour faire face à la
délinquance en rapport avec la drogue, les politiques de réduction des dommages apparaissent dans plusieurs états,
particulièrement dans l’ouest.
Summary: The topic of harm reduction programs for illegal substances in the U.S.A. today is a rather minimal
endeavor, in spite of these programs began here during the 1970s. The dominant method of handling users of
illegal drugs since 1980 has increasingly become the criminal justice system. This is reflected in increases in arrests
for drug offenses and increases in the numbers of persons in prisons convicted of drug offenses. Despite, and in
some cases in reaction to, the immense expansion of the use of criminal law and incarceration in the handling of
drug offenders, harm reduction policies are emerging in several states, particularly in the west.
Palabras clave: Drogas, Derecho penal, Sistema de justicia penal, Programas de reducción de daños.
Hitzik garrantzizkoenak: Drogak, Zuzenbide penala, justizi penalaren sistema, min murrizketarako programak.
Mots clef: Drogues, Droit Pénal, Système de justice pénale, Programmes de réduction des dommages.
Key words: Drugs, Penal Law, Penal justice system, Harm reduction programs.
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Harm reduction programs began in the U.S.A. during the 1970s1. The most
dramatic change of the time was the depenalization of the possession of small
amounts of cannabis for personal use at the state level. Beginning in 1973 with the
state of Oregon, eleven states eventually depenalized possession of small amounts of
cannabis. Possession became subject to a small fine, for example $100 to $200.
Approximately one third of the population of the nation resides in these eleven states.
Methadone substitution programs spread rapidly in the late 1960s and early
1970s. Fueled in part by the perception of widespread intravenous use of heroin by
U.S. military personnel in Vietnam –which was later shown to be false, even the con-
servative Nixon administration supported the spread of methadone treatment pro-
grams. By 1973, however, critics of methadone programs had mounted a
“regulatory counter attack” that resulted in a complex set of restrictive regulations
(see Rosenbaum, 1997).
Thirdly, programs were started to provide sterile syringes to users. These pro-
grams emerged in cities with high rates of IV heroin use such as Tacoma, Washing-
ton and San Francisco, California. Sterile syringe programs in the U.S.A. have often
been quasi-legal or overlooked by local legal authorities.
The topic of harm reduction programs for illegal substances in the U.S.A. today
is a rather minimal endeavor, however. As is widely known, the dominant method of
handling users of illegal drugs since the Reagan Administration took office in 1980
has increasingly become the criminal justice system. This is reflected in increases in
arrests for drug offenses and increases in the numbers of persons in prisons convic-
ted of drug offenses.
From 1980 to 2001 arrests for drug offenses increased about 425 percent. In
1999, 2000, and 2001 drug offenses were the most common form of crime for
which people were arrested for the first time in U.S. history. In 2001 nearly 1.6
million drug arrests were recorded. Eighty-one percent of these arrests were for pos-
session of an illegal substance and 41 percent of the total drug offense arrests were
for possession of cannabis (Maguire, and Flanagan, 1991; Maguire and Pastore,
2001; www.fbi.gov/ucr/ucr.htm).
Although the increase in arrests for drug offenses was substantial during past two
decades, the increase in prison populations has been much greater. The largest prison
complex in the U.S. is made up of the separate state systems. From 1980 to 2001,
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1. See Erickson, et al. (1997) and Erickson and Butters (1998) for overviews of harm reduction
principles and strategies.
the number of persons in state prisons for drug offenses increased by 1,220 percent.
In the smaller federal system, the number of persons in prison for drug offenses incre-
ased by 1,370 percent during the same time period. In 2001 there were an estimated
321,000 persons in prison for drug offenses (www.ojp.usdoj.gov/bjs/prisons.htm.)2.
The larger growth in prison populations than in arrests leads this author to conclude
that a much larger proportion of persons who are arrested for drug violations are
going to prison now than in the past (see also Everett, 1998).
This movement toward the increased use of prison to handle drug offenders can
be conceptualized as harm maximization. Although minority racial/ethnic group
members and their communities have been the most severely impacted, the harms
engendered by this explosion in the use of incarceration for drug offenses in the
U.S.A. has widespread adverse consequences throughout society (see Tonry, 1995;
Everett, 1998; Christie, 2000; Jensen, Gerber, and Mosher, forthcoming).
MEDICINAL CANNABIS
Although the criminal law has been used as the primary mechanism with which
to handle users of illegal drugs in the U.S. for approximately the past twenty years,
there are new harm reduction programs emerging across the nation. These pro-
grams are coming primarily from grassroots efforts to achieve change in the punitive
American model. The foremost of these policy changes is in the medicinal use of
cannabis. In 1996 voters in the states of California and Arizona were the first to sup-
port propositions that allowed the use of cannabis for medical purposes.
Before we review these new state-level laws, it must be pointed out that canna-
bis “is a controlled substance under federal law and is classified in the most restricti-
ve of categories of drugs by the federal government. The federal Controlled
Substances Act of 1970 (CSA) places all federally controlled substances into one of
five ‘schedules,’ depending on the drug’s likelihood for abuse or dependence, and
whether the drug has an accepted medical use. Marijuana is classified under Schedu-
le I, the classification reserved for drugs that have been found by the federal govern-
ment to have a high abuse potential, lack of accepted safety under medical
supervision, and no currently accepted medical use… The CSA does not allow Sche-
dule I drugs to be dispensed upon a prescription, unlike drugs in the other schedules.
In particular, the CSA provides federal sanctions for possession, manufacture, distri-
bution or dispensing of Schedule I substances… except in the context of a govern-
ment-approved research project” (U.S. General Accounting Office, 2002: 6). Thus,
these new state laws are in direct conflict with federal law.
The California law took effect on November 6, 1996. It removes the state-level
criminal penalties on the use, possession, and cultivation of cannabis by patients who
possess “a written or oral recommendation” from their physician that he or she
“would benefit from medical marijuana.” Patients diagnosed with any debilitating ill-
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2. A person is sentenced to prison in the U.S.A. when their sentence is one year or more of
incarceration.
ness for which the medical use of cannabis has been “deemed appropriate and has
been recommended by a physician” are afforded legal protection under this law.
Specific medical conditions for which cannabis can be recommended are not speci-
fied in the law. No limits were set regarding the amount of cannabis patients may
possess and/or cultivate in this Act. The Act did not establish a patient registry.
Some local jurisdictions have developed guidelines for amounts in possession and
registries, however (U.S. General Accounting Office, 2002)3.
The Arizona Drug Medicalization, Prevention, and Control Act took effect on
December 6, 1996. One part of the Act sought to seek legal protections for seriously
ill patients by allowing doctors to “prescribe” Schedule I controlled substances such
as cannabis. Because federal law ultimately forbids physicians from prescribing Sche-
dule I drugs, however, this statute does not adequately protect patients from state-
level criminal penalties as do similar state laws that only require “recommendation”
that medical marijuana therapy may be beneficial. A separate section of this propo-
sition which precludes prison sentences for the possession of small amounts of illegal
drugs does apply to medical patients. The Arizona attorney general’s office reports
that physicians in the state are not advocating medicinal cannabis to their patients
under this law (www.norml.org).
The Arizona state government attempted to stop the implementation of this
law. A bill signed by the Governor on April 21, 1997 sought to repeal the medical
marijuana law. This bill was placed on the ballot in the November 3, 1998 election
and was rejected by voters with a vote of 57 percent to 43 percent (www.norml.org).
Thus, the law which took effect in 1996 continues to be in effect today.
The 1996 Arizona law also contained mandated alternative sentencing for non-
violent drug offenders. We will return to this harm reduction effort in the next section
of the paper.
Medicinal cannabis laws have subsequently been enacted in seven other states
and the District of Columbia: Alaska in 1998, Oregon in 1998, Washington in
1998, Maine in 1999, Colorado in 2000, Hawaii in 2000, and Nevada in 2000. A
number of similar features are found in these state laws:
– they remove state-level criminal penalties on the use, possession, and cultiva-
tion of cannabis by patients who possess written documentation from their
physician affirming that he or she suffers from a debilitating condition and
advising that they may benefit from the medical use of marijuana (Alaska, Cali-
fornia, Colorado, Hawaii, Maine –or oral recommendation, Nevada, Oregon,
Washington)
– patients diagnosed with specified illnesses are afforded legal protection under
these laws. Illnesses frequently specified in these laws are: cachexia, cancer
with chronic pain, Crohn’s disease, pain or chronic pain, epilepsy and other
disorders characterized by seizures, glaucoma, HIV or AIDS, multiple sclerosis
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3. It must be noted that California depenalized possession of small amounts of cannabis for personal
use in 1976.
and other disorders characterized by muscle spasticity, and nausea (Alaska,
Colorado, Hawaii, Maine, Oregon)
– other conditions may be added by state boards of health (Alaska, Colorado,
Hawaii, Nevada, Oregon, Washington)
– an amount of cannabis allowed in possession or cultivation by patients or their
primary caregivers is specified in the law (Alaska, Colorado, Hawaii, Maine,
Nevada, Oregon, Washington)
– the state establishes and maintains a confidential registry that issues identifying
cards to qualifying patients to avoid arrest for possession of cannabis (Alaska,
Colorado, Hawaii, Nevada, Oregon)
Voters in the District of Columbia (i.e., Washington, D.C.) also passed an initia-
tive legalizing the use of cannabis for medicinal purposes in 1998. The enactment of
this initiative was blocked by the U.S. Congress as part of an appropriation bill for
the District of Columbia local government (the “Barr Amendment”), however. The
District of Columbia does not have the degree of autonomy that the states enjoy. It is
administratively controlled by the federal government. Thus, Congress has the aut-
hority to block such local initiatives. The “Barr Amendment” also prohibits the city
from ever lowering or eliminating penalties for use of Schedule I drugs (including can-
nabis and MDMA), even for medical use. This section of the Barr Amendment is
being challenged in federal court.
ISSUES OF SUPPLY
The major obstacle in making cannabis available to patients for medicinal use is
the absence of a legal supply of the drug. Cannabis currently is being supplied by ille-
gal growers and “cannabis clubs” that exist to assist patients in obtaining the drug.
This is somewhat similar to the Dutch dilemma with coffee shops where the supply
coming in the back door is illegal and the cannabis going out the front door is legal4.
Although local authorities in California and the western portion of Washington
state have generally been tolerating these illegal sources of supply, the federal Drug
Enforcement Administration (DEA) has acted to close a number of the sources of
supply in California.
One U.S. Supreme Court decision has been rendered on the legality of suppl-
ying medicinal cannabis to patients. In U.S. v. Oakland Cannabis Buyers’ Coope-
rative, 532 U.S. 483 (2001), the Court reversed and remanded a decision from a
lower federal court, and held that there was no medical-necessity exception to the
Controlled Substances Act’s prohibition of the medical use of cannabis. The Court
ruled that although the Act did not explicitly abrogate such an exception, it was clear
from the text of the Act that Congress had made a determination that cannabis had
no medical benefits that deserved an exception.
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4. I would like to thank Justin Nelson for suggesting this analogy.
The DEA raids have received very negative reactions in northern California.
Recently a large demonstration was held in Sacramento, the capital of the state, pro-
testing these raids. In addition, several local law enforcement agencies in northern
California have refused future cooperation with the DEA because of their raids on
medicinal cannabis suppliers.
Another sanction threatened by the federal government was to revoke a physi-
cian’s license to prescribe drugs if he/she recommended cannabis to patients for
medicinal purposes. A federal appeals court recently ruled on this proposed action.
In October 2002 the Ninth Circuit Court of Appeals three-judge panel in San Fran-
cisco unanimously upheld the right of physicians to recommend cannabis to their
patients and for patients to receive that recommendation. The Court ruled that such
a prohibition would interfere with the free-speech rights of physicians and patients.
Chief Circuit Judge Mary Schroeder wrote “An integral component of the practice of
medicine is the communication between doctor and a patient. Physicians must be
able to speak frankly and openly to patients”(Conant v. Walters, 309 F.3d 629, 9th
Cir. 2002). In a concurring opinion, Judge Alex Kozinski wrote that there exists a
wealth of evidence that may support the usefulness of medicinal cannabis. He also
commented that the federal government attacked physicians as a means to paralyze
California’s medicinal cannabis laws. This case was brought by patients’ rights
groups, and physicians who said they have been fearful of recommending cannabis
even if it is in a patient’s best interests.
The Sociopolitical Climates of the States
Several observations can be made about the passage of these medicinal canna-
bis laws. First, all of these jurisdictions with the exception of Maine and the District of
Columbia are in the western portion of the U.S.A. The reason(s) underlying this
dominance of western states in the establishment of medicinal cannabis laws is not
completely clear. One reason may be that the states of California, Oregon, and Was-
hington are rather liberal, by U.S. standards—although California was a leader in the
swing to the political right in the U.S. during much of the 1970s and the 1980s. On
the other hand, Arizona and Colorado are not in the liberal camp.
In addition, residence in the west seems to engender populist reactions to many
forms of imposition by the federal government. This tendency is pronounced in Arizona,
Nevada, and Alaska. Other western states such as Idaho, Montana, and Wyoming share
this populism but have not been involved in the medical cannabis movement, however.
Further, five of these states were among the first to depenalize the possession of
cannabis in the mid-1970s. These states include Alaska, Oregon, California, Maine
and Colorado. Depenalization may have laid the groundwork for the passage of
medical cannabis initiatives.
Citizen Initiatives: Grassroots Efforts
Another interesting sociopolitical thread that runs through most of these new
medicinal cannabis laws is that in all cases, with the exception of Hawaii, they were
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enacted through the citizen initiative process. This process is rather unique in wes-
tern democracies. Initiatives are organized by obtaining a specified percentage of the
signatures of registered voters in a state to place a proposed new law on the ballot. It
is then subject to a vote in that state. In this way, citizens can place issues on the
ballot without going through the machinery of formal government—except for a
verifications of the registered voter status of the signatories and of the minimum
number of signatures needed to place the issue on the ballot. In my experience thus
far this type of system exists only in the U.S.A., Switzerland, and the state of Berlin.
Another feature of these initiatives is that they are supported and assisted by
Non-governmental Organizations (NGOs) such as the Drug Policy Alliance, the Ame-
rican Civil Liberties Union, the Campaign for New Drug Policies, and the Massachu-
setts Cannabis Reform Coalition. These NGOs provide funding, information, and/or
organizational strategies to the grassroots groups that spearhead such initiatives. In
some cases, they also provide direct lobbying efforts.
The November 2002 Elections
A number of harm reduction measures were on the ballot in the November
2002 elections in states and municipalities across the nation. Although most of these
measures were defeated, several bills related to medicinal cannabis were supported
by the voters. San Francisco approved an initiative that requires city officials to
explore the possibility of growing and distributing medicinal cannabis.
This initiative was largely in reaction to the DEA raids on medicinal cannabis
suppliers in California. A three-member committee will be appointed to hold hea-
rings and bring professional expertise in exploring the legal and medical ramifica-
tions of the program.
Massachusetts voters supported initiatives in 21 districts to allow medical can-
nabis patients to grow and possess the substance. These initiatives are non-binding
and are intended to inform lawmakers of the will of the people in their districts. That
is, the passage of these initiatives did not create new legislation. These initiatives also
asked legislators to vote in favor of legislation that would depenalize the possession
of cannabis and to allow farmers in the state to grow industrial hemp.
THE MOVEMENT TOWARD TREATMENT INSTEAD OF INCARCERATION
Another part of the Drug Medicalization, Prevention and Control Act of 1996
passed by voters in Arizona, required that non-violent drug offenders arrested for
simple possession or use of an illegal drug must receive drug treatment instead of a
penal sentence for their first and second offenses (www.drugpolicyalliance.com).
This was the first such law in the U.S. but received much less attention in the media
than a similar law passed later in California.
An analysis by the Arizona Supreme Court found that this legislation diverted
2,600 non-violent offenders into drug treatment in its first year, saving Arizona tax-
payers $2.56 million. Over three-fourths of the offenders tested drug-free after com-
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pleting the program. A follow-up Supreme Court study in 2001 found that the law
saved over $6 million in prison costs in its second year. The Supreme Court conclu-
ded, “The Drug Medicalization, Prevention, and Control Act of 1996 has allowed
the judicial branch to build an effective probation model to treat and supervise subs-
tance abusing offenders…” (www.drugpolicyalliance.com).
In 2000 voters in California supported a similar initiative. Proposition 36 (the
Substance Abuse and Crime Prevention Act) allows first and second time non-vio-
lent, drug possession offenders the opportunity to receive substance abuse treatment
instead of incarceration. The law took effect July 1, 2001. It also allocated $120
million annually for five and one half years to pay for treatment services (www.drug-
policyalliance.com). Although this initiative followed the first one of this type in Ari-
zona, it received much more attention in the media, possibly because California is
the most populous state and it tends to be a national trend setter.
One of the factors behind voter support for this initiative was the explosion in
drug offenders imprisoned in California and the associated financial costs. Between
1980 and 1999 the number of people in prison for drug offenses in California incre-
ased from 1,778 to 45,455—or 2,556 percent. In comparison, between 1980 and
1995 the adult population of the state grew by 20 percent (Longshore, Hser, Pren-
dergast, Evans and Anglin, 2002). Those in prison for simple possession of illegal
drugs comprised 12.3 percent of the state’s prison population in 2000 (www.dru-
greform.org).
Prior to the vote on this initiative, the California Legislative Analyst’s office pro-
jected that passage of the initiative would save the state $200 million to $250 million
per year in reduced state prison operating costs within several years after implemen-
tation. In addition, it was projected that by slowing the growth of the prison popula-
tion, this law would delay or make unnecessary the construction of a new prison, with
capital savings of between $450 million and $550 million (www.drugreform.org).
Within the first ten months after it took effect, this law was responsible for diver-
ting over 12,500 individuals into treatment instead of prison in five counties alone.
In California, it costs $26,894 per year to place a person in prison, and an average
of $4,500 to place a person in treatment (www.prop36.org). The decrease in incar-
ceration of female drug offenders has been so substantial that some lawmakers are
considering closing one or two of the four women’s prisons to help reduce Califor-
nia’s budget deficit (www.drugpolicyalliance.com). After the first year following
enactment of the law, there were 3,955 fewer persons in prison for possession of
illegal substances than in the prior year (www.drugreform.org)
In 2002 the Washington state Legislature passed two bills of interest for this
article. The first made it legal for individuals to possess syringes and for pharmacies
to distribute them. The second allowed for expanded community-based treatment for
drug offenders and restored broader sentencing discretion to judges. This law goes
further than the Arizona or California initiatives by reducing prison terms for low-
level heroin or cocaine drug sellers from 24 months to 18 months, in addition to
those for possession (Goodman, n.d.; www.drugpolicy.org). In addition, a specified
amount of the funding saved from reduced incarceration costs due to these shorter
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sentences will be spent on in-community and prison-based treatment programs
(Goodman, n.d.) These changes in the laws are somewhat unique in that they were
enacted by the state legislature, not a voter initiative.
In the November 2002 elections the voters of the District of Columbia passed a
measure similar to those in Arizona and California. This initiative requires that per-
sons convicted of drug possession for a non-violent offense receive treatment instead
of incarceration. This law contains no funding to assist in implementing this change
in policy, however.
CONCLUSION
Drug control policies in the U.S.A. have reached new heights of punitiveness
since former President Reagan formally declared his War on Drugs in 1986 and for-
mer President Bush advocated prison sentences for persons convicted of the posses-
sion of illegal drugs (see Everett, 1998). Despite, and in some cases in reaction to,
this immense expansion of the use of criminal law and incarceration in the handling
of drug offenders, harm reduction policies are emerging in several states, particularly
in the west. Those of us who advocate harm reduction policies are encouraged by
these changes and the dedicated efforts of a number of NGOs to alter the harmful
trajectory in U.S. drug policy.
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